SMTL ID : 4y8x.1

Factor XIa in complex with the inhibitor methyl (4-{4-chloro-2-[(1S)-1-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-phenylethyl]-1H-imidazol-5-yl}phenyl)carbamate

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x 4GR: methyl (4-{4-chloro-2-[(1S)-1-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-phenylethyl]-1H-imidazol-5-yl}phenyl)carbamate(Non-covalent)

4GR.1: 29 residues within 4Å: Chain A: R.26, H.27, L.28, C.29, H.44, C.45, Y.134, L.137, I.141, D.182, A.183, C.184, K.185, G.186, D.187, S.188, T.206, S.207, W.208, G.209, E.210, G.211, C.212, G.219, V.220, Y.221 Ligands: EDO.4, EDO.7, EDO.8 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.28, A:Y.134, A:I.141, A:T.206 Hydrogen bonds: A:H.27, A:K.185, A:G.186, A:D.187, A:S.188, A:S.188 Water bridges: A:L.28, A:H.44, A:S.188

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 9 residues within 4Å: Chain A: V.8, R.9, G.10, E.11, W.12, P.13, I.61, L.62, L.145 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:G.10, A:E.11, A:W.12, A:W.12, A:I.61 SO4.3: 2 residues within 4Å: Chain A: R.161, R.177 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.161, A:R.177

9 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.4: 4 residues within 4Å: Chain A: K.185 Ligands: 4GR.1, EDO.7, EDO.8 1 PLIP interactions: 1 interactions with chain A Water bridges: A:K.185 EDO.5: 5 residues within 4Å: Chain A: N.36, T.102, V.103, G.104, Y.105 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.36, A:Y.105 EDO.6: 1 residues within 4Å: Chain A: R.9 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.9 Water bridges: A:N.63 EDO.7: 8 residues within 4Å: Chain A: L.137, K.185, G.209, E.210, G.211 Ligands: 4GR.1, EDO.4, EDO.8 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:G.211 Water bridges: A:K.185 EDO.8: 7 residues within 4Å: Chain A: E.89, W.208, G.209, E.210 Ligands: 4GR.1, EDO.4, EDO.7 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.210 Water bridges: A:G.209, A:G.209 EDO.9: 3 residues within 4Å: Chain A: K.166, T.168, H.169 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.169 EDO.10: 5 residues within 4Å: Chain A: I.34, G.35, L.114, T.235, Q.236 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Q.236 EDO.11: 8 residues within 4Å: Chain A: V.153, E.157, R.161, G.175, Y.176, R.177, E.216, P.218 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:E.157, A:E.157, A:R.161, A:Y.176 Water bridges: A:E.216 EDO.12: 2 residues within 4Å: Chain A: K.195, W.200 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:K.195

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hu, Z. et al., Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' Moiety. ACS Med Chem Lett (2015)

Release Date

2015-05-27

Peptides

Coagulation factor XIa: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Coagulation factor XIa

Related Entries With Identical Sequence